Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975 Jun;79(3):387-434.

Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy

Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy

B J Maron et al. Am J Pathol. 1975 Jun.

Abstract

Degenerated cardiac muscle cells were present in hypertrophied ventricular muscle obtained at operation from 12 (38%) of 32 patients with asymmetric septal hypertrophy (hypertrophic cardiomyopathy) or aortic valvular disease. Degenerated cells demonstrated a wide variety of ultrastructural alterations. Mildly altered cells were normal-sized or hypertrophied and showed focal changes, including preferential loss of thick (myosin) filaments, streaming and clumping of Z band material, and proliferation of the tubules of sarcoplasmic reticulum. Moderately and severely degenerated cells were normal-sized or atrophic and showed additional changes, including extensive myofibrillar lysis and loss of T tubules. The appearance of the most severely degenerated cells usually reflected the cytoplasmic organelle (sarcoplasmic reticulum, glycogen, or mitochondria) which underwent proliferation and filled the myofibril-free areas of these cells. Moderately and severely degenerated cells were present in areas of fibrosis, had thickened basement membranes, and had lost their intercellular connections. These observations suggest that degenerated cardiac muscle cells have poor contractile function and may be responsible for impaired cardiac performance in some patients with chronic ventricular hypertrophy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lab Invest. 1962 Jul;11:549-62 - PubMed
    1. J Mol Biol. 1963 Sep;7:281-308 - PubMed
    1. Lab Invest. 1963 Nov;12:1060-71 - PubMed
    1. Exp Cell Res. 1964 Dec;36:568-78 - PubMed
    1. J Pharmacol Exp Ther. 1965 Jan;147:112-9 - PubMed

MeSH terms

LinkOut - more resources